Consistent with the results presented here, previous case reports showed that patients with heterozygous c.1001G>A ALPL variants do not demonstrate symptoms of HPP (Huggins et al., 2020; Hofmann et al., 2014). This evidence concerns the gene ALPL and hypophosphatasia.